Whether it’s Trump or Clinton, biotech is in for ‘a moment of change’

Whether it’s Trump or Clinton, biotech is in for ‘a moment of change’-stat: This November, the biotech industry faces an awkward decision: Donald Trump, whose policy stances have proven unpredictable; or Hillary Clinton, who can scythe drug company stock prices with a single tweet.